Precision Medicine Precision medicine is an approach to treating diseases that takes into account the individuality of the patient and the uniqueness of their disease. The ultimate goal of precision medicine is to personalize medical treatments to each patient in order to achieve the best outcomes. The emerging concept of precision medicine in nephrology has been characterized by advances in biological and genetic research. Precision medicine allows kidney doctors to use genetic testing, biomarkers, and kidney biopsy results to not only give you a more precise diagnosis, but also provide treatment options tailored specifically for you. Currently, there are no FDA-approved medications for Nephrotic Syndrome diseases, but there are many potential treatments being tested in clinical trials. Some of these trials are based on precision medicine: Goldfinch Bio, Inc. is conducting a precision medicine clinical trial specifically for TRPC5-mediated FSGS. The Goldfinch Bio GFB-887 clinical trial uses urine biomarkers to help predict which patients may most likely respond to their clinical trial. Vertex Pharmaceuticals is conducting a precision medicine clinical trial specifically for APOL1-mediated FSGS. The Vertex VX-147 clinical trial uses genetic testing to help predict which patients may most likely respond to their clinical trial. Overall, the potential benefits of precision medicine spotlight the ongoing need for participation in clinical trials, to hopefully reduce the burden of kidney disease around the world. If you are interested in the promise of precision medicine and getting the best treatment options, visit Kidney Health Gateway to see if you are eligible to participate in a clinical trial near you. Interested in learning more about precision medicine? Click below to watch recordings of our NephCure U webinar series covering precision medicine. NephCure U: Understanding your Kidney Biopsy NephCure U: Improving Diagnosis with Biomarkers in Kidney Disease NephCure U: The Genetics of Rare Kidney Disease References 1. Precision medicine in nephrology. Nat Rev Nephrol 16, 615 (2020). https://doi.org/10.1038/s41581-020-00360-9 2. https://www.goldfinchbio.com/pipeline/gfb-887/ 3. https://www.vrtx.com/research-development/pipeline/apol1-mediated-kidney-diseases/